Northern Trust
AVBP icon

Northern Trust’s ArriVent BioPharma AVBP Stock Holding History

Northern Trust’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
332,753
+63,941
+24% +$1.89M ﹤0.01% 2137
2026
Q1 		$6.2M Buy
268,812
+23,213
+9% +$524K ﹤0.01% 2349
2025
Q4 		$4.94M Buy
245,599
+14,432
+6% +$300K ﹤0.01% 2484
2025
Q3 		$4.27M Buy
231,167
+24,412
+12% +$480K ﹤0.01% 2596
2025
Q2 		$4.5M Sell
206,755
-30,946
-13% -$643K ﹤0.01% 2516
2025
Q1 		$4.4M Sell
237,701
-3,308
-1% -$81K ﹤0.01% 2491
2024
Q4 		$6.42M Buy
241,009
+10,498
+5% +$301K ﹤0.01% 2370
2024
Q3 		$5.42M Buy
230,511
+152,321
+195% +$3.46M ﹤0.01% 2426
2024
Q2 		$1.45M Sell
78,190
-219
-0.3% -$3.9K ﹤0.01% 3077
2024
Q1 		$1.4M Buy
+78,409
New +$1.58M ﹤0.01% 3155

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust's AVBP Position: Q2 2026 in Review

Northern Trust increased its ArriVent BioPharma (AVBP) stake by 24% in Q2 2026, buying an estimated $1.89M and bringing the position to 332,753 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Northern Trust first reported a position in AVBP in Q1 2024 and has held it in 10 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Northern Trust held 332,753 shares of ArriVent BioPharma worth $11.6M as of Q2 2026.
  • Northern Trust bought 63,941 ArriVent BioPharma shares in Q2 2026, an estimated $1.89M.
  • ArriVent BioPharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2137 holding.
  • Northern Trust first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 10 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.